Target intelligence / Profile preview

Neisseria meningitidis serogroup B Porin A (PorA)

Target
PorA
Molecular classification
Porin, Outer membrane protein, Bacterial antigen
01

Overview

Porin A (PorA) is a major class 1 outer membrane protein found in Neisseria meningitidis, particularly within serogroup B. It functions as a cation-selective porin that forms channels in the bacterial outer membrane, allowing the passive diffusion of small hydrophilic molecules (UniProt: P0A316). In the field of vaccinology, PorA is a highly immunodominant antigen and a primary component of outer membrane vesicle (OMV) vaccines. These vaccines, such as the OMV component of Bexsero, are designed to elicit protective bactericidal antibodies against the bacterium (Pollard et al., 2009). A significant challenge in targeting PorA is its high degree of sequence variability in the extracellular loops (VR1 and VR2), which defines the serosubtype and often limits the breadth of protection to specific bacterial strains (Sacchi et al., 1998). Consequently, modern meningococcal B vaccines often combine OMV-derived PorA with other conserved recombinant proteins to ensure broader coverage across diverse clinical isolates.

Other names
Class 1 outer membrane proteinPorin AMenB OMV PorAnMB_0543Major outer membrane protein P1
02

Mechanism of action

Induction of serum bactericidal antibodies (SBA) that recognize specific epitopes on the PorA protein, facilitating complement-mediated lysis and opsonophagocytosis of Neisseria meningitidis (EMA: Bexsero Summary of Product Characteristics).

03

Biological functions

Passive diffusion of hydrophilic solutesCation-selective pore formationMembrane permeabilityImmune response induction
04

Disease associations

Meningococcal meningitisMeningococcal sepsisInfection
05

Safety considerations

Antigenic variation leading to limited cross-strain protectionInjection site reactogenicity associated with OMV-based vaccinesPotential for endotoxin-mediated systemic reactions
06

Interacting drugs

Bexsero (Meningococcal Group B Vaccine)

3 more in the full profile.

07

Biomarkers

Serum bactericidal antibody (SBA) titerPorA serosubtype (VR1 and VR2 sequences)

Beyond the preview

Go deeper on Neisseria meningitidis serogroup B Porin A (PorA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis serogroup B Porin A (PorA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call